Asia Pacific Neurological Biomarkers Market Size, Share & Industry Trends Analysis Report By Type, By Application, By Country and Growth Forecast, 2022

List of Tables

The Asia Pacific Neurological Biomarkers Market would witness market growth of 15.0% CAGR during the forecast period (2022-2028).

Neurofilament light (NFL), a biomarker for a neuronal injury that denotes head trauma, is one type of biomarker that Quanterix can evaluate in blood. A team led by Kaj Blennow and Henrik Zetterberg at the University of Gothenburg in Molndal, Sweden, has discovered that college football players' levels of the biomarker NFL increased during a football season, but not in contact-free control athletes.

Hrusovsky hopes that parents and coaches will be able to evaluate the effects of athletes' head injuries without invasive testing on the sidelines of soccer or football games. He hopes that early detection and surveillance will stop the development of more complicated disorders like CTE. Another effective approach for researching neurological disorders and conditions is the identification of biomarker signatures using panels of high-quality antibodies.

The prevalence of neurological illnesses is a significant social and economic issue. They are the biggest cause of disability and the second leading cause of mortality. The incidence, prevalence, mortality, and impairment rates of neurological illnesses have increased internationally during the past 25 years despite the deployment of methods and intervention programs to lessen the burden, primarily due to population aging and growth.

An excess or deficiency of this energy, known as Vata, can cause the neurological system to become overactive or weak. Ayurvedic texts include more than 80 neurological disorders. Additionally, 2018 Parkinson's NSW, Monash University, and the University of Melbourne predicted that by 2034, there will be 212,000 Australians living with Parkinson's disease, a 79 percent increase in prevalence. The demand for neuromodulators is rising as neurological illnesses become more prevalent since they can treat neurological symptoms. These factors will speed up the development of the neurological biomarkers market in this region.

The China market dominated the Asia Pacific Neurological Biomarkers Market by Country in 2021; thereby, achieving a market value of $1,010 Million by 2028. The Japan market is anticipated to grow at a CAGR of 14.3% during (2022 - 2028). Additionally, The India market would obtain a CAGR of 15.7% during (2022 - 2028).

Based on Type, the market is segmented into Proteomic, Genomic, Metabolomic and Others. Based on Application, the market is segmented into Alzheimer's Disease, Parkinson's Disease and Multiple Sclerosis. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Australia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include F. HOFFMANN-LA ROCHE LTD., Bio-Rad Laboratories, Inc., Merck Group, PERKINELMER INC., Shimadzu corporation, Thermo Fisher Scientific, Inc., Quanterix Corporation, Neuro-Bio Ltd., BioMerieux S.A. and Myriad Genetics, Inc.

Scope of the Study

Market Segments covered in the Report:

By Type

Proteomic
Genomic
Metabolomic
Others

By Application

Alzheimer's Disease
Parkinson's Disease
Multiple Sclerosis

By Country

China
Japan
India
South Korea
Singapore
Australia
Rest of Asia Pacific

Companies Profiled

F. HOFFMANN-LA ROCHE LTD.
Bio-Rad Laboratories, Inc.
Merck Group
PERKINELMER INC.
Shimadzu corporation
Thermo Fisher Scientific, Inc.
Quanterix Corporation
Neuro-Bio Ltd.
BioMerieux S.A.
Myriad Genetics, Inc.

Unique Offerings from KBV Research

Exhaustive coverage
Highest number of market tables and figures
Subscription based model available
Guaranteed best price
Assured post sales research support with 10% customization free

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 Asia Pacific Neurological Biomarkers Market, by Type
- 1.4.2 Asia Pacific Neurological Biomarkers Market, by Application
- 1.4.3 Asia Pacific Neurological Biomarkers Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview

2.1 Introduction
- 2.1.1 Overview
  - 2.1.1.1 Market Composition & Scenarios
2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints

Chapter 3. Asia Pacific Neurological Biomarkers Market by Type

3.1 Asia Pacific Proteomic Market by Country
3.2 Asia Pacific Genomic Market by Country
3.3 Asia Pacific Metabolomic Market by Country
3.4 Asia Pacific Others Market by Country

Chapter 4. Asia Pacific Neurological Biomarkers Market by Application

4.1 Asia Pacific Alzheimer's Disease Market by Country
4.2 Asia Pacific Parkinson's Disease Market by Country
4.3 Asia Pacific Multiple Sclerosis Market by Country

Chapter 5. Asia Pacific Neurological Biomarkers Market by Country

5.1 China Neurological Biomarkers Market
- 5.1.1 China Neurological Biomarkers Market by Type
- 5.1.2 China Neurological Biomarkers Market by Application
5.2 Japan Neurological Biomarkers Market
- 5.2.1 Japan Neurological Biomarkers Market by Type
- 5.2.2 Japan Neurological Biomarkers Market by Application
5.3 India Neurological Biomarkers Market
- 5.3.1 India Neurological Biomarkers Market by Type
- 5.3.2 India Neurological Biomarkers Market by Application
5.4 Australia Neurological Biomarkers Market
- 5.4.1 Australia Neurological Biomarkers Market by Type
- 5.4.2 Australia Neurological Biomarkers Market by Application
5.5 South Korea Neurological Biomarkers Market
- 5.5.1 South Korea Neurological Biomarkers Market by Type
- 5.5.2 South Korea Neurological Biomarkers Market by Application
5.6 Singapore Neurological Biomarkers Market
- 5.6.1 Singapore Neurological Biomarkers Market by Type
- 5.6.2 Singapore Neurological Biomarkers Market by Application
5.7 Rest of Asia Pacific Neurological Biomarkers Market
- 5.7.1 Rest of Asia Pacific Neurological Biomarkers Market by Type
- 5.7.2 Rest of Asia Pacific Neurological Biomarkers Market by Application

Chapter 6. Company Profiles

6.1 F. Hoffmann-La Roche Ltd.
- 6.1.1 Company Overview
- 6.1.2 Financial Analysis
- 6.1.3 Segmental and Regional Analysis
- 6.1.4 Research & Development Expense
6.2 Bio-Rad laboratories, Inc.
- 6.2.1 Company Overview
- 6.2.2 Financial Analysis
- 6.2.3 Segmental and Regional Analysis
- 6.2.4 Research & Development Expenses
6.3 Merck Group
- 6.3.1 Company Overview
- 6.3.2 Financial Analysis
- 6.3.3 Segmental and Regional Analysis
- 6.3.4 Research & Development Expense
- 6.3.5 Recent strategies and developments:
  - 6.3.5.1 Partnerships, Collaborations, and Agreements:
6.4 PerkinElmer, Inc.
- 6.4.1 Company Overview
- 6.4.1 Financial Analysis
- 6.4.2 Segmental and Regional Analysis
- 6.4.3 Research & Development Expense
6.5 Shimadzu Corporation
- 6.5.1 Company Overview
- 6.5.2 Financial Analysis
- 6.5.3 Segmental and Regional Analysis
6.6 Thermo Fisher Scientific, Inc.
- 6.6.1 Company Overview
- 6.6.2 Financial Analysis
- 6.6.3 Segmental and Regional Analysis
- 6.6.4 Research & Development Expense
6.7 BioMerieux S.A.
- 6.7.1 Company Overview
- 6.7.2 Financial Analysis
- 6.7.3 Segmental and Regional Analysis
- 6.7.4 Research & Development Expenses
6.8 Myriad Genetics, Inc.
- 6.8.1 Company Overview
- 6.8.2 Financial Analysis
- 6.8.3 Segmental Analysis
- 6.8.4 Research & Development Expenses
6.9 Quanterix Corporation
- 6.9.1 Company Overview
- 6.9.2 Financial Analysis
- 6.9.3 Segmental and Regional Analysis
- 6.9.4 Research & Development Expenses
- 6.9.5 Recent strategies and developments:
  - 6.9.5.1 Partnerships, Collaborations, and Agreements:
6.10. Neuro-Bio Ltd.
- 6.10.1 Company Overview

LIST OF TABLES

TABLE 1 Asia Pacific Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 2 Asia Pacific Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 3 Asia Pacific Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 4 Asia Pacific Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 5 Asia Pacific Proteomic Market by Country, 2018 - 2021, USD Million
TABLE 6 Asia Pacific Proteomic Market by Country, 2022 - 2028, USD Million
TABLE 7 Asia Pacific Genomic Market by Country, 2018 - 2021, USD Million
TABLE 8 Asia Pacific Genomic Market by Country, 2022 - 2028, USD Million
TABLE 9 Asia Pacific Metabolomic Market by Country, 2018 - 2021, USD Million
TABLE 10 Asia Pacific Metabolomic Market by Country, 2022 - 2028, USD Million
TABLE 11 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 12 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 13 Asia Pacific Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 14 Asia Pacific Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 15 Asia Pacific Alzheimer's Disease Market by Country, 2018 - 2021, USD Million
TABLE 16 Asia Pacific Alzheimer's Disease Market by Country, 2022 - 2028, USD Million
TABLE 17 Asia Pacific Parkinson's Disease Market by Country, 2018 - 2021, USD Million
TABLE 18 Asia Pacific Parkinson's Disease Market by Country, 2022 - 2028, USD Million
TABLE 19 Asia Pacific Multiple Sclerosis Market by Country, 2018 - 2021, USD Million
TABLE 20 Asia Pacific Multiple Sclerosis Market by Country, 2022 - 2028, USD Million
TABLE 21 Asia Pacific Neurological Biomarkers Market by Country, 2018 - 2021, USD Million
TABLE 22 Asia Pacific Neurological Biomarkers Market by Country, 2022 - 2028, USD Million
TABLE 23 China Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 24 China Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 25 China Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 26 China Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 27 China Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 28 China Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 29 Japan Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 30 Japan Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 31 Japan Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 32 Japan Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 33 Japan Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 34 Japan Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 35 India Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 36 India Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 37 India Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 38 India Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 39 India Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 40 India Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 41 Australia Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 42 Australia Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 43 Australia Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 44 Australia Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 45 Australia Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 46 Australia Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 47 South Korea Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 48 South Korea Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 49 South Korea Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 50 South Korea Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 51 South Korea Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 52 South Korea Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 53 Singapore Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 54 Singapore Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 55 Singapore Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 56 Singapore Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 57 Singapore Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 58 Singapore Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 59 Rest of Asia Pacific Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 60 Rest of Asia Pacific Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 61 Rest of Asia Pacific Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 62 Rest of Asia Pacific Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 63 Rest of Asia Pacific Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 64 Rest of Asia Pacific Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 65 KEY INFORMATION - F. Hoffmann-La Roche Ltd.
TABLE 66 Key Information - Bio-Rad Laboratories, Inc.
TABLE 67 key Information - Merck GrouP
TABLE 68 key Information - PerkinElmer, Inc.
TABLE 69 Key Information - Shimadzu Corporation
TABLE 70 Key Information - Thermo Fisher Scientific, Inc.
TABLE 71 Key information - BioMerieux S.A.
TABLE 72 Key Information - Myriad Genetics, Inc.
TABLE 73 Key Information - QUANTERIX CORPORATION
TABLE 74 Key Information - Neuro-Bio Ltd.

List of Figures

FIG 1 Methodology for the research

Asia Pacific Neurological Biomarkers Market Size, Share & Industry Trends Analysis Report By Type, By Application, By Country and Growth Forecast, 2022 - 2028

Description

Table of Contents